Back to Liraglutide research
liraglutide glp 1 agonist other 2007-11 ClinicalTrials

Genetic Variations in GLP-1 Receptor Influence Response to GLP-1 Therapy

GLP1R Polymorphisms and Response to GLP1

Study Design

Population
Not specified in the digest, but implied to be patients receiving GLP-1 therapy.
Intervention
GLP-1 therapy, specifically mentioning Liraglutide, with dose, route, and duration not specified.
Outcome
Response to GLP-1 therapy, influenced by genetic variations in the GLP-1 receptor.

Abstract

A Pilot Study Examining How Common Genetic Variation in GLP1R Alters Response to GLP1 Infusion NCT ID: NCT00588380 Status: COMPLETED Sponsor: Mayo Clinic Phase: NA Start: 2007-11 | Completion: 2010-09 Enrollment: 88 (ACTUAL) Conditions: Di…

liraglutide glp 1 agonist glp-1r
Source: clinicaltrials:NCT00588380 · Ingested 2026-05-05 · Digest: gemini-2.5-flash